German
€0.00*

Why is import authorisation necessary for medicinal products entering the EU?

  • Question of the Week

Import authorisation is mandatory for companies importing medicinal products from non-EU countries. It ensures compliance with GMP principles and designates a physical importation site, which must be listed in the permit, safeguarding product quality and safety.

[GMP:KnowHow Pharma Logistics (GDP), Chapter Approvals and authorisations]

Would you like to discover more?

GMP:KnowHow Pharma Logistics (GDP) is your perfect tool for GDP-compliant storage and transportation.

The free demo access is non-binding and ends automatically after 7 days. 

Test it now for free

You may also be interested in the following articles:

EC: EU and WHO Strengthen Cooperation on Pandemic Intelligence for Medical Countermeasures
News

EC: EU and WHO Strengthen Cooperation on Pandemic Intelligence for Medical Countermeasures

“Today public health faces a new kind of challenge: speed. Diseases move faster and are more unpredictable than ever, racing across borders and continents.”, said Hadja Lahbib, Commissioner for Equality, Preparedness and Crisis Management, upon signing an EU4Health contribution agreement worth over 4 million euros with the World Health Organisation’s (WHO) Hub for Pandemic and Epidemic Intelligence in Berlin on 24 July 2026.

Read more
PIC/S: Revised Recommendations on Qualification and Validation
News

PIC/S: Revised Recommendations on Qualification and Validation

PIC/S has published a fundamentally revised version of its “Recommendations on Qualification and Validation” (PI 006-4). The new document was issued on 30 July 2026, will enter into force on 1 October 2026, and replaces the 2007 edition. The revised document has been expanded from 26 to 49 pages.
Read more
How do Components like Filling Needles and Laminarisators Affect First Air Integrity?
Question of the Week

How do Components like Filling Needles and Laminarisators Affect First Air Integrity?

Here's the answer:
Read more
Smart Strategies for Handling Indirect Product Contact Components
LOGFILE Feature

Smart Strategies for Handling Indirect Product Contact Components

Aseptic filling processes: Handling indirect product contact parts in compliance with the revised Annex 1 of the EU GMP Guide.
Read more
Swissmedic: Implementation of New EU GMP Implementing Regulations for Veterinary Medicinal Products
News

Swissmedic: Implementation of New EU GMP Implementing Regulations for Veterinary Medicinal Products

The new EU Implementing Regulations on GMP requirements for veterinary medicinal products and active substances will not be automatically transposed into the Swiss Medicinal Products Licensing Ordinance (MPLO) on 16 July 2026. Swissmedic has confirmed that, although the structure of the new EU legislation has changed, the underlying GMP requirements remain largely unchanged.
Read more
EU: Annexes 4 and 5 no Longer Included in the EU GMP Guide
News

EU: Annexes 4 and 5 no Longer Included in the EU GMP Guide

Following the entry into application of Commission Implementing Regulations (EU) 2025/2091 and (EU) 2025/2154 on the principles and guidelines of Good Manufacturing Practice (GMP) for veterinary medicinal products and active substances for veterinary medicinal products on 16 July 2026, the European Commission removed Annexes 4 and 5 from the EU GMP Guide.
Read more
Previous
Next
This website uses cookies to ensure the best experience possible. More information...